Gray A M AM - OmicsDI

Show results for

Unknown (640)
Transcriptomics (18)
Proteomics (16)
Genomics (5)
Metabolomics (5)

Organisms

Homo sapiens (28)
Mus musculus (6)
Saccharomyces mikatae IFO 1815 (1)
Rattus norvegicus (1)
Arabidopsis thaliana (1)
Coprococcus sp. ART55/1 (1)
Xenopus laevis (1)

Repository

biostudies-arrayexpress (20)
pride (16)
MetaboLights (5)
EGA (3)

Tissue

Cell culture (11)
Blood (1)
Blood cell (1)
Epithelial cell (1)
HEK-293T cell (1)
Heart (1)
Monocyte (1)
Neutrophil (1)
Oocyte (1)
Pancreas (1)
Permanent cell line cell (1)
Platelet (1)

Disease

Small cell lung carcinoma (1)
Gray platelet syndrome (1)
Pancreatic ductal adenocarcinoma (1)

Technology Type

Mass Spectrometry (16)
Mass spectrometry (5)
Shotgun proteomics (5)
Data-dependent acquisition (4)
Data-independent acquisition (3)
Affinity purification coupled with mass spectrometry proteomics (2)
Affinity proteomics (1)
DiaPASEF (1)

Instrument Platform

Illumina NovaSeq 6000 (2)
Liquid Chromatography MS - negative - reverse phase (2)
Liquid Chromatography MS - positive - reverse phase (2)
10X Chromium Controller (1)
Axon GenePix 4000A scanning hardware (1)
Liquid Chromatography MS - alternating (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)
Q Exactive (1)

Publication Date

2025 (8)
2024 (5)
2013 (3)
2011 (3)
2026 (2)
2012 (2)
2010 (2)
2006 (2)
2019 (2)
2020 (2)
2016 (1)
2015 (1)
2014 (1)
2009 (1)
2008 (1)
2005 (1)
2023 (1)
2022 (1)
2021 (1)
2018 (1)

CHEBI ID

CHEBI:15354 (3)
CHEBI:15891 (3)
CHEBI:16010 (3)
CHEBI:16040 (3)
CHEBI:16704 (3)
CHEBI:16708 (3)
CHEBI:17568 (3)
CHEBI:73024 (3)
CHEBI:116314 (2)
CHEBI:132983 (2)
CHEBI:14336 (2)
CHEBI:15676 (2)
CHEBI:15721 (2)
CHEBI:15741 (2)
CHEBI:15746 (2)
CHEBI:15756 (2)
CHEBI:15760 (2)
CHEBI:15824 (2)
CHEBI:15940 (2)
CHEBI:15971 (2)
CHEBI:16235 (2)
CHEBI:16335 (2)
CHEBI:16344 (2)
CHEBI:16349 (2)
CHEBI:16359 (2)
CHEBI:16393 (2)
CHEBI:16411 (2)
CHEBI:16610 (2)
CHEBI:16643 (2)
CHEBI:16668 (2)

Metabolite Name

5-oxoproline (2)
Adenine (2)
Choline (2)
Cytosine (2)
Taurine (2)
(+/-)-CP 47,497-C7-Hydroxy metabolite (1)
(+/-)11(12)-DiHET (1)
(+/-)12(13)-DiHOME (1)
(+/-)5(6)-EET (1)
(+/-)5(6)-EET Ethanolamide (1)
(-)-Caryophyllene oxide (1)
(11E,15Z)-9,10,13-trihydroxyoctadeca-11,15-dienoic acid (1)
(12Z)-9,10,11-trihydroxyoctadec-12-enoic acid (1)
(1E)-5-hydroxy-1,7-diphenylhept-1-en-3-one (1)
(1E,4E)-1,5-bis(4-methoxyphenyl)penta-1,4-dien-3-one (1)
(1R,2R)-trans-N-Boc-1,2-cyclohexanediamine (1)
(2,6-dimethylmorpholino)(1-methyl-5-nitro-1H-pyrazol-4-yl)methanone (1)
(2E)-6-hydroxy-2-methyl-6-(4-methylphenyl)hept-2-enoic acid (1)
(2E,4E)-N-(2-methylpropyl)deca-2,4-dienamide (1)
(2E,4E)-N-(2-methylpropyl)dodeca-2,4-dienamide (1)
(2E,4E)-N-[2-(4-hydroxyphenyl)ethyl]dodeca-2,4-dienamide (1)
(2R)-2-[(2R,5S)-5-[(2S)-2-hydroxybutyl]oxolan-2-yl]propanoic acid (1)
(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(2-phenylethoxy)oxane-3,4,5-triol (1)
(3beta,9xi)-3-(beta-D-Glucopyranosyloxy)-14-hydroxycard-20(22)-enolide (1)
(5-methyl-3-isoxazolyl)[4-(5-propyl-2-pyrimidinyl)piperazino]methanone (1)
(5E)-7-methylidene-10-oxo-4-(propan-2-yl)undec-5-enoic acid (1)
(5Z)-3-aminonon-5-enoic acid (1)
(6E)-7-(2H-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)hept-6-en-1-one (1)
(6E,10E)-3,7,11,15-tetramethylhexadeca-1,6,10,14-tetraene-3,5,9-triol (1)
(S)-Bromoenol lactone (1)

Study type

Transcription profiling by array (10)
RNA-seq of coding RNA (3)
Comparative genomic hybridization by array (2)
ChIP-seq (2)
Unknown experiment type (1)
Methylation profiling by array (1)
RNA-seq of coding RNA from single cells (1)

Release Date

2024 (78)
2021 (78)
2023 (70)
2022 (67)
2025 (64)
2020 (41)
2018 (34)
2019 (31)
2015 (27)
2017 (26)
2016 (22)
2013 (20)
2011 (19)
2014 (17)
2012 (16)
2026 (12)
2010 (12)
2008 (9)
2009 (8)
2006 (5)
2005 (2)
2007 (2)

Lab affiliation

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA (9)
Biological Chemistry and Molecular Pharmacology, Harvard Medical School Cancer Biology, Dana-Farber Cancer Institute (1)
Charles Perkins Centre, School of Life and Environmental Sciences, University of Sydney, Camperdown, NSW, Australia. (1)
Dana Farber Cancer Institute (1)
Department of Neurobiology and Developmental Science, University of Arkansas for Medical Sciences, Little Rock, AR (1)
Fred Hutch Cancer Center, Human Biology Division (1)
Leibniz-Institut für Analytische Wissenschaften – ISAS – e.V. Otto-Hahn-Straße 6b 44227 Dortmund, Germany P: +49 (0)2 31.13 92-100 F: +49 (0)2 31.13 92-200 www.isas.de (1)
Rowett Institute Gut Health Theme University of Aberdeen Foresterhill Aberdeen AB25 2ZD (1)

Previous page
1 / 69
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 69
Next page

Sort by:

Relevance

Page size

Novel manifestations of immune dysregulation and granule defects in gray platelet syndrome.

Comparitive proteomics analyses of different cell types of blood i.e. platelets, neutrophils, monocytes and CD4 derived from the Gray platelet syndrome patients and their respective controls using TMT10plex reagents.

ORGANISM(S): Homo sapiens (Human)

2020-07-23 | PXD016366 | Pride

In Vivo Evidence of Reduced Integrity of the Gray-White Matter Boundary in Autism Spectrum Disorder.

Not available

S-EPMC6093436 | biostudies-literature

The missing role of gray matter in studying brain controllability.

Not available

S-EPMC7935040 | biostudies-literature

Comparative genomic hybridization of cell lines from 9 different cancer tissue of origin types (Breast, Central Nervous System, Colon, Leukemia, Melanoma, Non-Small Cell Lung, Ovarian, Prostate, Renal) from NCI-60 panel

Array comparative genomic hybridization characterization and comparison of cell lines from 9 different cancer tissue of origin types (Breast, Central Nervous System, Colon, Leukemia, Melanoma, Non-Small Cell Lung, Ovarian, Prostate, Renal) from NCI-60 panel.

ORGANISM(S): Homo sapiens

2005-11-23 | E-TABM-65 | biostudies-arrayexpress

Genome binding profile of the conserved CSB-PGBD3 fusion protein in CSB-null UVSS1KO cells

The CSB-PGBD3 fusion protein arose over 43 million years ago when a 2.5 kb piggyBac 3 (PGBD3) transposon inserted into intron 5 of the Cockayne syndrome Group B (CSB) gene in the common ancestor of all higher primates. The CSB-PGBD3 fusion protein binds internally-deleted PGBD3 elements called MER85...

ORGANISM(S): Homo sapiens

2012-07-10 | E-GEOD-37919 | biostudies-arrayexpress

Structural gray matter features and behavioral preliterate skills predict future literacy - A machine learning approach.

Not available

S-EPMC9558903 | biostudies-literature

Gray-matter volume, midbrain dopamine D2/D3 receptors and drug craving in methamphetamine users.

Not available

S-EPMC4440838 | biostudies-literature

Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals.

Not available

S-EPMC2688870 | biostudies-literature

Gray matter maturation and cognition in children with different APOE ε genotypes.